Society of Surgical Oncology–American Society for Radiation Oncology–American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma In Situ
暂无分享,去创建一个
Irene Wapnir | Stuart J. Schnitt | Monica Morrow | Nehmat Houssami | S. Schnitt | Jay R. Harris | N. Houssami | M. Morrow | L. Solin | M. Chávez-MacGregor | I. Wapnir | M. Moran | K. V. Van Zee | Lawrence J. Solin | J. Horton | Meena S. Moran | Janet Horton | Mariana Chavez-MacGregor | Peggy L. Johnson | Shelley Hwang | Kimberly J. Van Zee | M. Luke Marinovich | J. Harris | S. Hwang | M. Marinovich
[1] M. Morrow,et al. Decreasing Recurrence Rates for Ductal Carcinoma In Situ: Analysis of 2996 Women Treated with Breast-Conserving Surgery Over 30 Years , 2015, Annals of Surgical Oncology.
[2] E. Hwang,et al. Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ. , 2015, Journal of the National Cancer Institute.
[3] J. Cuzick,et al. A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trial , 2010, British Journal of Cancer.
[4] P. Bult,et al. Three dimensional imaging of mammary ductal carcinoma in situ: clinical implications. , 1994, Seminars in diagnostic pathology.
[5] R. Gray,et al. Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 Study. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] S. Martino,et al. The influence of margin width on local control of ductal carcinoma in situ of the breast. , 1999, The New England journal of medicine.
[7] Y. Li,et al. The clinical features and management of women with ductal carcinoma in situ with microinvasion: A retrospective Cohort study. , 2015, International journal of surgery.
[8] G. Noël,et al. [Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853]. , 2001, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.
[9] Surgeon recommendations and receipt of mastectomy for treatment of breast cancer. , 2009, JAMA.
[10] J. Peterse,et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] Barbara L. Smith,et al. RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] George W. Sledge,et al. A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast , 2013, Journal of the National Cancer Institute.
[13] L. Holmberg,et al. SweDCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening , 2006, Acta oncologica.
[14] J. Cuzick,et al. Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial , 2010, The Lancet. Oncology.
[15] M. Morrow,et al. Relationship Between Margin Width and Recurrence of Ductal Carcinoma In Situ: Analysis of 2996 Women Treated With Breast-conserving Surgery for 30 Years. , 2015, Annals of surgery.
[16] S. Shak,et al. A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone , 2015, Breast Cancer Research and Treatment.
[17] D G Altman,et al. Bayesians and frequentists , 1998, BMJ.
[18] B. Haffty,et al. Ductal carcinoma in situ with microinvasion: prognostic implications, long-term outcomes, and role of axillary evaluation. , 2008, International journal of radiation oncology, biology, physics.
[19] J. Geddes,et al. What is a randomised controlled trial? , 2009, Epidemiologia e Psichiatria Sociale.
[20] M. Morrow,et al. Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] L. Irwig,et al. The Association of Surgical Margins and Local Recurrence in Women with Ductal Carcinoma In Situ Treated with Breast-Conserving Therapy: A Meta-Analysis , 2016, Annals of Surgical Oncology.
[22] Benjamin D. Smith,et al. Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline. , 2011, International journal of radiation oncology, biology, physics.
[23] E. van Limbergen,et al. Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial. , 2015, The Lancet. Oncology.
[24] Seema A Khan,et al. Society of Surgical Oncology–American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer , 2014, Annals of Surgical Oncology.
[25] J. Houghton. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomized controlled trial , 2003, The Lancet.
[26] H. Bartelink,et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] T. Julian,et al. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. , 2011, Journal of the National Cancer Institute.
[28] Ping Sun,et al. Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ. , 2015, JAMA oncology.
[29] S. Schnitt,et al. The relationship between shaved margin and inked margin status in breast excision specimens , 1997, Cancer.
[30] Reshma Jagsi,et al. What is an Adequate Margin for Breast-Conserving Surgery? Surgeon Attitudes and Correlates , 2010, Annals of Surgical Oncology.
[31] Seema A Khan,et al. Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] Lawrence B Marks,et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). , 2009, Journal of the American College of Surgeons.
[33] R. Peto,et al. Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. , 2010, Journal of the National Cancer Institute. Monographs.
[34] D. Carter. Margins of "lumpectomy" for breast cancer. , 1986, Human pathology.
[35] J. Costantino,et al. Pathologic findings from the national surgical adjuvant breast project (NSABP) protocol B‐17: Intraductal carcinoma (ductal carcinoma in situ) , 2006 .
[36] Barbara L. Smith,et al. Eight-year update of a prospective study of wide excision alone for small low- or intermediate-grade ductal carcinoma in situ (DCIS) , 2013, Breast Cancer Research and Treatment.